light chain amyloidosis

J&J’s Darzalex Faspro is first US therapy for rare blood disorder
Pharmaforum
Mon, 01/18/21 - 06:25 pm
JNJ
Darzalex Faspro
FDA
light chain amyloidosis
Janssen files Darzalex Faspro for rare disease light chain amyloidosis
Pharmaforum
Sat, 09/12/20 - 10:16 pm
JNJ
Janssen
Darzalex Faspro
light chain amyloidosis
EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win
Fierce Pharma
Sat, 06/13/20 - 11:31 pm
light chain amyloidosis
JNJ
Darzalex
EHA
Alexion Strikes Development Deal With Caelum Biosciences in Rare Systemic Disorder
BioSpace
Thu, 01/31/19 - 11:18 am
Alexion Pharmaceuticals
Fortress Biotech
Caelum Biosciences
CAEL-101
light chain amyloidosis